Abstract
Introduction Recently, higher relaxivity contrasts agents have been advocated for use in infarct imaging. Specifically, MultiHance® (gadobenate dimeglumine) has higher relaxivities (r1 and r2, 9.71 and 12.51) compared to standard Magnevist (gadopentetate dimeglumine) (r1 and r2, 4.91 and 6.31). Will this higher relaxivity show better visualization of subendocardial infarcts or hinder the visualization?
Highlights
Higher relaxivity contrasts agents have been advocated for use in infarct imaging
Abstracts of the 13th Annual SCMR Scientific Sessions - 2010 Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/files/pdf/1532-429X-12-S1-info
T-Tests were performed on the ratio between the MultiHance® and Magnevist at 10 (p=ns)and 20 (p
Summary
June Yamrozik*, Vikas K Rathi, Ronald B Williams, Janice Meister, Geetha Rayarao, Diane A Vido, Mark Doyle and Robert WW Biederman. Address: The Center for Cardiovascular Magnetic Resonance Imaging, The Gerald McGinnis Cardiovascular Institute at Allegheny General Hospital, Pittsburgh, PA, USA. Published: 21 January 2010 Journal of Cardiovascular Magnetic Resonance 2010, 12(Suppl 1):T11 doi:10.1186/1532-429X-12-S1-T11. Abstracts of the 13th Annual SCMR Scientific Sessions - 2010 Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/files/pdf/1532-429X-12-S1-info
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.